Your browser doesn't support javascript.
loading
Impact of drug resistance-associated amino acid changes in HIV-1 subtype C on susceptibility to newer nonnucleoside reverse transcriptase inhibitors.
Basson, Adriaan E; Rhee, Soo-Yon; Parry, Chris M; El-Khatib, Ziad; Charalambous, Salome; De Oliveira, Tulio; Pillay, Deenan; Hoffmann, Christopher; Katzenstein, David; Shafer, Robert W; Morris, Lynn.
Afiliação
  • Basson AE; Centre for HIV and STIs, National Institute for Communicable Diseases (NICD), part of the National Health Laboratory Service (NHLS), Johannesburg, South Africa University of the Witwatersrand, Johannesburg, South Africa.
  • Rhee SY; Division of Infectious Diseases, Stanford University Medical Center, Stanford, California, USA.
  • Parry CM; Antiviral Unit Virus Reference Department, Health Protection Agency (HPA), London, United Kingdom MRC/UCL Center for Medical Molecular Virology, UCL, London, United Kingdom MRC/UVRI Research Unit on AIDS, Uganda Virus Research Institute, Entebbe, Uganda.
  • El-Khatib Z; Centre for HIV and STIs, National Institute for Communicable Diseases (NICD), part of the National Health Laboratory Service (NHLS), Johannesburg, South Africa Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
  • Charalambous S; The Aurum Institute, Johannesburg, South Africa.
  • De Oliveira T; Africa Centre for Health and Population Studies, University of KwaZulu-Natal, Mtubatuba, South Africa.
  • Pillay D; Antiviral Unit Virus Reference Department, Health Protection Agency (HPA), London, United Kingdom MRC/UCL Center for Medical Molecular Virology, UCL, London, United Kingdom.
  • Hoffmann C; The Aurum Institute, Johannesburg, South Africa Johns Hopkins University, Center for TB Research, School of Medicine, Baltimore, Maryland, USA.
  • Katzenstein D; Division of Infectious Diseases, Stanford University Medical Center, Stanford, California, USA.
  • Shafer RW; Division of Infectious Diseases, Stanford University Medical Center, Stanford, California, USA.
  • Morris L; Centre for HIV and STIs, National Institute for Communicable Diseases (NICD), part of the National Health Laboratory Service (NHLS), Johannesburg, South Africa University of the Witwatersrand, Johannesburg, South Africa lynnm@nicd.ac.za.
Antimicrob Agents Chemother ; 59(2): 960-71, 2015 Feb.
Article em En | MEDLINE | ID: mdl-25421485
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: HIV-1 / Inibidores da Transcriptase Reversa Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2015 Tipo de documento: Article País de afiliação: África do Sul
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: HIV-1 / Inibidores da Transcriptase Reversa Tipo de estudo: Risk_factors_studies Limite: Humans Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2015 Tipo de documento: Article País de afiliação: África do Sul